caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1861431405

Michael HughM.D.

Allergy/ ImmunologyPoughkeepsie, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
499
Unique beneficiaries
—
Total services
7,435
Distinct HCPCS
5
Medicare payment
$56K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 272 Allergy/ Immunology providers in NY — top quintile (cohort median 2,067).
REFERRAL NETWORK

Where Michael Hugh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2354
George Pazos
Otolaryngology · Yorktown Heights, NY
2145
Rami Payman
Otolaryngology · Poughkeepsie, NY
1737
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1425
Mark Very
Otolaryngology · Poughkeepsie, NY
1257
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
618
Beneficiaries
—
Total drug cost
$35K
Distinct drugs
10
Brand share
16.8%
Top prescribed drugs
Fluticasone Propionate229 claims
Azelastine Hcl193 claims
Fluticasone Furoate64 claims
Montelukast Sodium33 claims
Cefdinir22 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
89.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$149
Payment records
8
By payment type
Food and Beverage$149